<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Ispecimen Inc — News on 6ix</title>
<link>https://6ix.com/company/ispecimen-inc</link>
<description>Latest news and press releases for Ispecimen Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Fri, 24 Apr 2026 13:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/ispecimen-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835859878dffbe2df0fd941.webp</url>
<title>Ispecimen Inc</title>
<link>https://6ix.com/company/ispecimen-inc</link>
</image>
<item>
<title>iSpecimen Announces 1-for-40 Reverse Stock Split</title>
<link>https://6ix.com/company/ispecimen-inc/news/ispecimen-announces-1-for-40-reverse-stock-split</link>
<guid isPermaLink="true">https://6ix.com/company/ispecimen-inc/news/ispecimen-announces-1-for-40-reverse-stock-split</guid>
<pubDate>Fri, 24 Apr 2026 13:00:00 GMT</pubDate>
<description>Woburn, Massachusetts--(Newsfile Corp. - April 24, 2026) - iSpecimen Inc. (NASDAQ: ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today that it will effect a reverse stock split of its issued and outstanding shares of common stock, par value $0.0001 per share, as well as any shares of common stock held by the Company in treasury, at a ratio of...</description>
</item>
<item>
<title>iSpecimen Launches AI Agent Revolutionizing Biospecimen Matching</title>
<link>https://6ix.com/company/ispecimen-inc/news/ispecimen-launches-ai-agent-revolutionizing-biospecimen-matching-1</link>
<guid isPermaLink="true">https://6ix.com/company/ispecimen-inc/news/ispecimen-launches-ai-agent-revolutionizing-biospecimen-matching-1</guid>
<pubDate>Thu, 12 Mar 2026 20:05:00 GMT</pubDate>
<description>Strengthens iSpecimen’s next-generation marketplace platform Woburn, MA, March 12, 2026 (GLOBE NEWSWIRE) -- iSpecimen Inc. (the “Company”) (NASDAQ: ISPC), a leading technology marketplace connecting researchers with biospecimen suppliers, today announced the launch of its new AI-powered Inventory Agent, a purpose-built tool designed to help accelerate the process of reviewing incoming biospecimen requests and matching them with available inventory across its global supplier network. The internal</description>
</item>
<item>
<title>iSpecimen Announces Milestone 2: System Integration and Marketplace Activation Complete</title>
<link>https://6ix.com/company/ispecimen-inc/news/ispecimen-announces-milestone-2-system-143000605</link>
<guid isPermaLink="true">https://6ix.com/company/ispecimen-inc/news/ispecimen-announces-milestone-2-system-143000605</guid>
<pubDate>Fri, 06 Feb 2026 14:30:00 GMT</pubDate>
<description>Live Production Marketplace Now AvailableWoburn, Massachusetts--(Newsfile Corp. - February 6, 2026) - iSpecimen Inc. (NASDAQ: ISPC) today announced the successful completion of Milestone 2, System Integration and Marketplace Activation, marking a pivotal step in the SalesStack digital transformation journey. The milestone delivers a fully integrated, live marketplace that connects customer requests with supplier inventories, enabling streamlined operations, reduced costs, and a foundation for...</description>
</item>
<item>
<title>iSpecimen Achieves Rapid Procurement Milestone for Influenza Research</title>
<link>https://6ix.com/company/ispecimen-inc/news/ispecimen-achieves-rapid-procurement-milestone-132000901</link>
<guid isPermaLink="true">https://6ix.com/company/ispecimen-inc/news/ispecimen-achieves-rapid-procurement-milestone-132000901</guid>
<pubDate>Fri, 06 Feb 2026 13:20:00 GMT</pubDate>
<description>Lexington, Massachusetts--(Newsfile Corp. - February 6, 2026) - iSpecimen Inc. (NASDAQ: ISPC), a leading provider of human biospecimens for research, is proud to announce recent milestones that demonstrate the strength, responsiveness, and reliability of its site network.Over the past several months, iSpecimen has been actively supporting customer research by sourcing high-quality respiratory samples, with a particular focus on influenza. Most recently, iSpecimen successfully collected 500...</description>
</item>
<item>
<title>E.F. Hutton & Co. Acts as Exclusive Placement Agent in iSpecimen Inc.’s ~$5.5 Million Private Placement</title>
<link>https://6ix.com/company/ispecimen-inc/news/ef-hutton-and-co-acts-as-exclusive-placement-agent-in-ispecimen-incs-dollar55-million-private-placement</link>
<guid isPermaLink="true">https://6ix.com/company/ispecimen-inc/news/ef-hutton-and-co-acts-as-exclusive-placement-agent-in-ispecimen-incs-dollar55-million-private-placement</guid>
<pubDate>Tue, 06 Jan 2026 15:00:00 GMT</pubDate>
<description>MANHATTAN, N.Y., Jan. 06, 2026 (GLOBE NEWSWIRE) -- E.F. Hutton & Co., a Manhattan-headquartered investment bank and broker-dealer, today announced that it acted as the exclusive placement agent in connection with iSpecimen Inc.’s (Nasdaq: ISPC) private placement, raising approximately $5.5 million in gross proceeds before fees and expenses. The transaction reflects continued capital markets interest in differentiated healthcare technology platforms that support medical research and discovery. iS</description>
</item>
<item>
<title>iSpecimen Inc. Announces Pricing of ~$5.5 Million Private Placement</title>
<link>https://6ix.com/company/ispecimen-inc/news/ispecimen-inc-announces-pricing-5-193700015</link>
<guid isPermaLink="true">https://6ix.com/company/ispecimen-inc/news/ispecimen-inc-announces-pricing-5-193700015</guid>
<pubDate>Tue, 30 Dec 2025 19:37:00 GMT</pubDate>
<description>WOBURN, Mass., Dec. 30, 2025 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that it entered into a securities purchase agreement with accredited investors for aggregate gross proceeds of approximately $5.5 million, before deducting fees to the placement agent and other offering expenses payable by the</description>
</item>
<item>
<title>iSpecimen Announces Completion of Milestone 1 in Digital Transformation Journey with Salestack Platform</title>
<link>https://6ix.com/company/ispecimen-inc/news/ispecimen-announces-completion-milestone-1-120000443</link>
<guid isPermaLink="true">https://6ix.com/company/ispecimen-inc/news/ispecimen-announces-completion-milestone-1-120000443</guid>
<pubDate>Thu, 21 Aug 2025 12:00:00 GMT</pubDate>
<description>Woburn, Massachusetts--(Newsfile Corp. - August 21, 2025) - iSpecimen Inc. (NASDAQ: ISPC), an online marketplace for human biospecimens, today announced the successful completion of Milestone 1 in its digital transformation program powered by Salestack Solutions. This critical achievement marks the installation of the Salestack platform and provisioning of modern infrastructure—laying the foundation for accelerated innovation, operational efficiency, and long-term scalability.Milestone 1 focused</description>
</item>
<item>
<title>iSpecimen Inc. Announces Closing of Approximately $1.75 Million Private Placement Priced At-the-Market</title>
<link>https://6ix.com/company/ispecimen-inc/news/ispecimen-inc-announces-closing-approximately-224500729</link>
<guid isPermaLink="true">https://6ix.com/company/ispecimen-inc/news/ispecimen-inc-announces-closing-approximately-224500729</guid>
<pubDate>Mon, 04 Aug 2025 22:45:00 GMT</pubDate>
<description>WOBURN, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that it closed its previously announced private placement pursuant to a securities purchase agreement with accredited investors for aggregate gross proceeds of approximately $1.75 million, before deducting fees to the placemen</description>
</item>
<item>
<title>iSpecimen Inc. Announces Pricing of Approximately $1.75 Million Private Placement Priced At-the-Market</title>
<link>https://6ix.com/company/ispecimen-inc/news/ispecimen-inc-announces-pricing-approximately-200600755</link>
<guid isPermaLink="true">https://6ix.com/company/ispecimen-inc/news/ispecimen-inc-announces-pricing-approximately-200600755</guid>
<pubDate>Thu, 31 Jul 2025 20:06:00 GMT</pubDate>
<description>WOBURN, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that it entered into a securities purchase agreement with accredited investors for aggregate gross proceeds of approximately $1.75 million, before deducting fees to the placement agent and other offering expenses payable by th</description>
</item>
<item>
<title>Correction: iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering</title>
<link>https://6ix.com/company/ispecimen-inc/news/correction-ispecimen-inc-announces-closing-203500341</link>
<guid isPermaLink="true">https://6ix.com/company/ispecimen-inc/news/correction-ispecimen-inc-announces-closing-203500341</guid>
<pubDate>Mon, 28 Jul 2025 20:35:00 GMT</pubDate>
<description>WOBURN, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- This press release corrects a version issued on July 25, 2025 that incorrectly listed KCSA Strategic Communications as iSpecimen’s investor relations contact. KCSA is not currently affiliated with iSpecimen Inc. and was mistakenly included in the prior release. The corrected release is below in its entirety. iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens fo</description>
</item>
<item>
<title>Correction: iSpecimen Inc. Announces Pricing of $4 Million Underwritten Offering</title>
<link>https://6ix.com/company/ispecimen-inc/news/correction-ispecimen-inc-announces-pricing-203000354</link>
<guid isPermaLink="true">https://6ix.com/company/ispecimen-inc/news/correction-ispecimen-inc-announces-pricing-203000354</guid>
<pubDate>Mon, 28 Jul 2025 20:30:00 GMT</pubDate>
<description>WOBURN, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- This press release corrects the version issued on July 24, 2025 that incorrectly listed KCSA Strategic Communications as iSpecimen’s investor relations contact. KCSA is not currently affiliated with iSpecimen Inc. and was mistakenly included in the prior release. The corrected release is below in its entirety. iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens</description>
</item>
<item>
<title>iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering</title>
<link>https://6ix.com/company/ispecimen-inc/news/ispecimen-inc-announces-closing-4-175300920</link>
<guid isPermaLink="true">https://6ix.com/company/ispecimen-inc/news/ispecimen-inc-announces-closing-4-175300920</guid>
<pubDate>Fri, 25 Jul 2025 17:53:00 GMT</pubDate>
<description>WOBURN, Mass., July 25, 2025 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today the closing of its previously announced underwritten public offering of 5,714,283 shares of its common stock (or pre-funded warrants to purchase common stock in lieu thereof) at a public offering price of $0.70 per share (the</description>
</item>
<item>
<title>iSpecimen Inc. Announces Pricing of $4 Million Underwritten Offering</title>
<link>https://6ix.com/company/ispecimen-inc/news/ispecimen-inc-announces-pricing-4-123000841</link>
<guid isPermaLink="true">https://6ix.com/company/ispecimen-inc/news/ispecimen-inc-announces-pricing-4-123000841</guid>
<pubDate>Thu, 24 Jul 2025 12:30:00 GMT</pubDate>
<description>WOBURN, Mass., July 24, 2025 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today the pricing of an underwritten public offering of 5,714,283 shares of its common stock (or pre-funded warrants to purchase common stock in lieu thereof) at a public offering price of $0.70 per share (the “Offering”). The aggre</description>
</item>
<item>
<title>iSpecimen Will Serve as a Preferred Provider of Cancer Biospecimens</title>
<link>https://6ix.com/company/ispecimen-inc/news/ispecimen-will-serve-as-a-preferred-provider-of-cancer-biospecimens</link>
<guid isPermaLink="true">https://6ix.com/company/ispecimen-inc/news/ispecimen-will-serve-as-a-preferred-provider-of-cancer-biospecimens</guid>
<pubDate>Fri, 20 Dec 2024 05:00:00 GMT</pubDate>
<description>Woburn, Massachusetts--(Newsfile Corp. - December 20, 2024) - iSpecimen Inc. (NASDAQ: ISPC), a leading online marketplace for human biospecimens, today</description>
</item>
<item>
<title>iSpecimen Appoints Robert Lim as CEO and Director</title>
<link>https://6ix.com/company/ispecimen-inc/news/ispecimen-appoints-robert-lim-as-ceo-and-director</link>
<guid isPermaLink="true">https://6ix.com/company/ispecimen-inc/news/ispecimen-appoints-robert-lim-as-ceo-and-director</guid>
<pubDate>Thu, 12 Dec 2024 05:00:00 GMT</pubDate>
<description>Woburn, Massachusetts--(Newsfile Corp. - December 12, 2024) - iSpecimen Inc. (NASDAQ: ISPC) ("iSpecimen" or the "Company"), an online global marketplace that</description>
</item>
<item>
<title>iSpecimen Reports Third Quarter 2024 Results</title>
<link>https://6ix.com/company/ispecimen-inc/news/ispecimen-reports-third-quarter-2024-results</link>
<guid isPermaLink="true">https://6ix.com/company/ispecimen-inc/news/ispecimen-reports-third-quarter-2024-results</guid>
<pubDate>Thu, 07 Nov 2024 05:00:00 GMT</pubDate>
<description>LEXINGTON, Mass., Nov. 07, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects</description>
</item>
<item>
<title>iSpecimen Releases Cancer Biospecimen Offering; Orders Anticipated of Over $9,500,000 Annually</title>
<link>https://6ix.com/company/ispecimen-inc/news/ispecimen-releases-cancer-biospecimen-offering-orders-anticipated-of-over-dollar9500000-annually</link>
<guid isPermaLink="true">https://6ix.com/company/ispecimen-inc/news/ispecimen-releases-cancer-biospecimen-offering-orders-anticipated-of-over-dollar9500000-annually</guid>
<pubDate>Thu, 07 Nov 2024 05:00:00 GMT</pubDate>
<description>WOBURN, Mass., Nov. 07, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects</description>
</item>
<item>
<title>iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants</title>
<link>https://6ix.com/company/ispecimen-inc/news/ispecimen-inc-announces-closing-of-dollar5-million-public-offering-of-common-stock-and-pre-funded-warrants</link>
<guid isPermaLink="true">https://6ix.com/company/ispecimen-inc/news/ispecimen-inc-announces-closing-of-dollar5-million-public-offering-of-common-stock-and-pre-funded-warrants</guid>
<pubDate>Thu, 31 Oct 2024 04:00:00 GMT</pubDate>
<description>WOBURN, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects</description>
</item>
<item>
<title>iSpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants</title>
<link>https://6ix.com/company/ispecimen-inc/news/ispecimen-inc-announces-pricing-of-dollar5-million-public-offering-of-common-stock-and-pre-funded-warrants</link>
<guid isPermaLink="true">https://6ix.com/company/ispecimen-inc/news/ispecimen-inc-announces-pricing-of-dollar5-million-public-offering-of-common-stock-and-pre-funded-warrants</guid>
<pubDate>Wed, 30 Oct 2024 04:00:00 GMT</pubDate>
<description>WOBURN, Mass., Oct. 30, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects</description>
</item>
<item>
<title>iSpecimen Announces 1-for-20 Reverse Stock Split</title>
<link>https://6ix.com/company/ispecimen-inc/news/ispecimen-announces-1-for-20-reverse-stock-split</link>
<guid isPermaLink="true">https://6ix.com/company/ispecimen-inc/news/ispecimen-announces-1-for-20-reverse-stock-split</guid>
<pubDate>Wed, 11 Sep 2024 04:00:00 GMT</pubDate>
<description>WOBURN, Mass., Sept. 11, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects</description>
</item>
</channel>
</rss>